SCHEMBL8312203

SCHEMBL8312203

CC1CCCCc2ccc([N+](=O)[O-])cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPT P10636 4/20 0.50
GAA P10253 3/20 0.50
ALPG P10696 1/20 0.50
HSP90AA1 P07900 1/20 0.49
PNMT P11086 5/20 0.44
ADRA2A P08913 3/20 0.44
ADRA2B P18089 2/20 0.44
ADRA2C P18825 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CHRNA7 P36544 1/20 0.44
LMNA P02545 2/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
HIF1A Q16665 1/20 0.42
CHRNB4 P30926 2/20 0.41
CHRNA3 P32297 2/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348868 0.82 HSP90AA1 (0.52) ALDH1A1MAPTHSP90AA1PNMTADRA2A
SCHEMBL8312961 0.78 HSP90AA1 (0.46) ALDH1A1MAPTHSP90AA1SMN1; SMN2LMNA
SCHEMBL13012423 0.78 HTR2C (0.57) PNMTADRA2AADRA2BADRA2CCHRNB4
SCHEMBL13012422 0.78 HTR2C (0.57) PNMTADRA2AADRA2BADRA2CCHRNB4
SCHEMBL16691532 0.78 HSP90AA1 (0.44) ALDH1A1MAPTHSP90AA1PNMTADRA2A
SCHEMBL7509358 0.77 HSP90AA1 (0.47) ALDH1A1MAPTHSP90AA1PNMTADRA2A
SCHEMBL6478814 0.77 HSP90AA1 (0.47) ALDH1A1MAPTHSP90AA1PNMTADRA2A
SCHEMBL394579 0.77 MEN1 (0.54) ALDH1A1MAPTHSP90AA1PNMTADRA2A
SCHEMBL30073945 0.77 HSP90AA1 (0.47) ALDH1A1MAPTHSP90AA1PNMTADRA2A
SCHEMBL23174854 0.77 SLC6A2 (0.50) ALDH1A1MAPTHSP90AA1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087124-A1 COMPOUNDS HAVING SEROTONIN 5-HT17 RECEPTOR ANTAGONIST ACTIVITY AND MUSCARINIC M4 RECEPTOR AGONIST ACTIVITY AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MITSUBISHI PHARMA CORPORATION (JP) 2004-10-14 WO disclosed